EP3116901

ADAPTIMMUNE LIMITED
Application Number
EP15709505A
Filing Date
Mar 13, 2015
Status
Granted And Under Opposition
May 10, 2019
Grant Date
Jun 12, 2019
External Links
Slate, Register

Biblio Summary

The patent EP3116901B1 was granted on Jun 12, 2019 by Adaptimmune Limited The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBMar 11, 2020ADMISSIBLE

The table below shows the patents of Adaptimmune Limited that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3373013Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexJul 19, 20233
EP3440104T Cell ReceptorsJun 14, 20231
EP3060668Vectors For Transgene ExpressionOct 19, 20221